A phase 3, open-label, controlled, randomized, multicenter trial evaluating the efficacy and safety of StrataGraft® construct in patients with deep partial-thickness thermal burns

Authors:

Abstract
No abstract available
Funding Information
  • BARDA
  • Mallinckrodt Pharmaceuticals

This publication has 13 references indexed in Scilit: